AI assistant
Sending…
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2016
May 16, 2016
32814_dirs_2016-05-16_198db59a-7103-4090-bbcc-eb565551b81e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2016-05-16
Reporting Person: TYLE PRAVEEN (EVP, R&D)
More from LEXICON PHARMACEUTICALS, INC.
Report Publication Announcement
2026
May 7
Capital/Financing Update
2026
May 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3